SCHEMBL20733812

SCHEMBL20733812

c1ccc(-c2nnc3c(n2)c2nc(-c4ccccc4)n(-c4ccccc4)c2c2c3nc(-c3ccccc3)n2-c2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AVPR1A P37288 1/20 0.44
▸ PI4KA P42356 1/20 0.43
▸ PI4K2B Q8TCG2 1/20 0.43
▸ PI4K2A Q9BTU6 1/20 0.43
▸ PI4KB Q9UBF8 1/20 0.43
▸ HTT P42858 1/20 0.39
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HCAR1 Q9BXC0 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ TSHR P16473 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ ESR1 P03372 1/20 0.36
▸ ESR2 Q92731 1/20 0.36
▸ KDM4C Q9H3R0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18493217 0.78 PI4KA (0.54) AVPR1API4KAPI4K2BPI4K2API4KB
SCHEMBL20733792 0.78 RAB9A (0.62) HTTNPC1RAB9AMAPK1ALDH1A1
SCHEMBL20733744 0.72 L3MBTL1 (0.42) AVPR1AHTTNPC1RAB9AMAPK1
SCHEMBL2631757 0.71 MEN1 (0.48) AVPR1API4KAPI4K2BPI4K2API4KB
SCHEMBL28979811 0.71 PI4KA (0.48) AVPR1API4KAPI4K2BPI4K2API4KB
SCHEMBL20733782 0.71 L3MBTL1 (0.40) AVPR1AHTTNPC1RAB9AMAPK1
SCHEMBL19988571 0.70 PI4KA (0.47) AVPR1API4KAPI4K2BPI4K2API4KB
SCHEMBL8930906 0.69 PI4KA (0.46) AVPR1API4KAPI4K2BPI4K2API4KB
SCHEMBL18415812 0.69 MEN1 (0.42) AVPR1API4KAPI4K2BPI4K2API4KB
SCHEMBL28576110 0.68 GAA (0.44) AVPR1API4KAPI4K2BPI4K2API4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230057590-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2023-02-23 — — US disclosed
US-20190051842-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2019-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230057590-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OXER1 AVPR1A 3678/4885PI4KA 2736/4885PI4K2B 2253/4885
US-20190051842-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OXER1 AVPR1A 3678/4885PI4KA 2736/4885PI4K2B 2253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback